title: Molecular determinants of ATP-sensitive potassium channel MgATPase activity: diabetes risk variants and diazoxide sensitivity.
abstract: ATP-sensitive K(+) (KATP) channels play an important role in insulin secretion. KATP channels possess intrinsic MgATPase activity that is important in regulating channel activity in response to metabolic changes, although the precise structural determinants are not clearly understood. Furthermore, the sulfonylurea receptor 1 (SUR1) S1369A diabetes risk variant increases MgATPase activity, but the molecular mechanisms remain to be determined. Therefore, we hypothesized that residue-residue interactions between 1369 and 1372, predicted from in silico modelling, influence MgATPase activity, as well as sensitivity to the clinically used drug diazoxide that is known to increase MgATPase activity. We employed a point mutagenic approach with patch-clamp and direct biochemical assays to determine interaction between residues 1369 and 1372. Mutations in residues 1369 and 1372 predicted to decrease the residue interaction elicited a significant increase in MgATPase activity, whereas mutations predicted to possess similar residue interactions to wild-type (WT) channels elicited no alterations in MgATPase activity. In contrast, mutations that were predicted to increase residue interactions resulted in significant decreases in MgATPase activity. We also determined that a single S1369K substitution in SUR1 caused MgATPase activity and diazoxide pharmacological profiles to resemble those of channels containing the SUR2A subunit isoform. Our results provide evidence, at the single residue level, for a molecular mechanism that may underlie the association of the S1369A variant with type 2 diabetes. We also show a single amino acid difference can account for the markedly different diazoxide sensitivities between channels containing either the SUR1 or SUR2A subunit isoforms.
authors.affiliation: Department of Pharmacology, Alberta Diabetes Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Fatehi
authors.affiliation: Department of Pharmacology, Alberta Diabetes Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1.
authors.forename: Chris R J
authors.initials: CR
authors.lastname: Carter
authors.affiliation: Department of Pharmacology, Alberta Diabetes Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1.
authors.forename: Nermeen
authors.initials: N
authors.lastname: Youssef
authors.affiliation: Department of Pharmacology, Alberta Diabetes Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1.
authors.forename: Beth E
authors.initials: BE
authors.lastname: Hunter
authors.affiliation: Department of Pharmacology, Alberta Diabetes Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1.
authors.forename: Andrew
authors.initials: A
authors.lastname: Holt
authors.affiliation: Department of Pharmacology, Alberta Diabetes Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada, T6G 2E1 peter.light@ualberta.ca.
authors.forename: Peter E
authors.initials: PE
authors.lastname: Light
mesh_terms: D019943:Amino Acid Substitution; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000378:metabolism; D003981:Diazoxide / Q000494:pharmacology*; D057809:HEK293 Cells; D006801:Humans; D020125:Mutation, Missense; D064233:Sulfonylurea Receptors / Q000235:genetics / Q000378:metabolism
chemical_list: C577507:ABCC8 protein, human; C577510:ABCC9 protein, human; D064233:Sulfonylurea Receptors; D003981:Diazoxide
keywords: ATPase; KATP channel; diabetes risk variant; diazoxide